Articles Published in 2008

Charles River’s Preclinical Growth Slows, Lowers Guidance

Thursday, November 6, 2008 10:48 AM

Wilmington, Mass.-based Charles River Laboratories saw slower than expected sales growth in its Preclinical Services Segment (PCS) during the third quarter, prompting the preclinical contract research organization (CRO) to reduce its 2008 profit and revenue-growth forecasts. Strong sales in Charles River’s Research Models and Services (RMS) segment helped offset the performance of PCS, but the company reduced the high-end of its full-year sales growth percentage forecast by 4%, from 14% to 10%.

More... »

WIRB Copernicus Group

Kendle’s Q3 Revenues Up 25%

Wednesday, November 5, 2008 01:02 PM

Cincinnati-based contract research organization (CRO) Kendle reported third quarter net service revenues of $124.8 million, an increase of 25% compared with the same period last year. Approximately 6% of the CRO’s revenue growth resulted from the June acquisition of DecisionLine, a Toronto-based phase I company focused on the central nervous system (CNS).

More... »


CenterWatch Monthly November 2008

Tuesday, November 4, 2008 09:00 AM

No Standard Policy for Conflicts of Interest

More... »

ASKA Research Partners with Japanese CRO

Monday, November 3, 2008 09:00 AM

ASKA Research, a contract research organization (CRO) based in Vancouver, Canada, is expanding its clinical trial services into Japan through a strategic partnership with Japanese CRO Asklep.

More... »

eResearch Revenues Up 41.5%, Shares Down 30%

Friday, October 31, 2008 11:43 AM

Philadelphia, Pa.-based eResearch Technology saw its revenue growth wane slightly in the third quarter but still maintained a 41.5% increase compared with the same period last year. The eClinical company reported net revenues for the quarter of $33.9 million up from $24 million in the third quarter of last year. Diluted net income per share was $0.13 compared with $0.07 in the third quarter of 2007, and gross margin was $19.1 million.

More... »

PharmaNet Revenues Drop

Thursday, October 30, 2008 10:43 AM

PharmaNet Development is the latest contract research organization (CRO) to release disappointing quarterly earnings as a result of contract cancellations, slow sales and negative foreign exchange rates. Princeton, N.J.-based PharmaNet reported a decrease in direct revenue to $89.2 million, down $10 million, or 10.6%, from the same period last year. Almost $1.5 million of that drop was a result of foreign currency exchange translation.

More... »

Phase Forward Revenues Up 23%

Wednesday, October 29, 2008 09:22 AM

Waltham, Mass.-based eClinical technology company Phase Forward reported a 23% jump in third quarter revenues to $43 million from $34.9 million in the third quarter of 2007.

More... »

Parexel Cuts 2009 Guidance, Shares Fall 40%

Tuesday, October 28, 2008 12:23 PM

Waltham, Mass.-based contract research organization Parexel reduced its 2009 fiscal year guidance, and share prices plunged more than 40% to $8.05 in late morning trading.

More... »

Preclinical CROs Expand Operations to Shanghai

Monday, October 27, 2008 09:36 AM

China has seen significant growth in the area of drug research and development in the past few years, and this growth will continue into the fourth quarter of 2008 with the opening of two new preclinical facilities in Shanghai.

More... »

Guest Commentary: CDASH—The Final Piece in the End-to-End eClinical Interoperability Puzzle

Friday, October 24, 2008 11:00 AM

By Douglas Bain, vice president, Global Operational Excellence, Medidata Solutions Worldwide

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 18

Ebola outbreak highlights need to improve biosafety, infrastructure to handle future health emergencies

More African American professional women open to participating in medical research

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs